Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides
- PMID: 6162806
- DOI: 10.1002/ijc.2910260216
Observations on the EB virus envelope and virus-determined membrane antigen (MA) polypeptides
Abstract
Experiments have been carried out to identify the polypeptide components of the Epstein-Barr (EB) virus-determined membrane antigen (MA) complex. Cells were radioiodinated using lactoperoxidase and the 125I-labelled surface antigens, released by Triton X100, were analysed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) after complexing either with human sera having anti-MA activity or with a rabbit antiserum to EB virus. Using cells carrying EB virus isolated from four different conditions, including for the first time nasopharyngeal carcinoma (NPC), we have demonstrated four major polypeptides. One, with a molecular weight of 85,000, was remarkedly constant irrespective of the cell line from which it came; two, with molecular weights varying from 240,000 to 270,000 and from 320,000 to 340,000, showed minor differences in mobility apparently depending on the species of origin of the cells (human or marmoset), rather than disparity between strains of virus. A fourth component, of 160,000 daltons, was found on only two of the cell lines studied. In addition, it has been shown for the first time that the same polypeptides composing the MA complex are present on the viral envelope itself. The fact that the rabbit antiserum to EV virus recognized only the two highest molecular weight MA components, yet showed virus-neutralizing activity, indicates the importance of these two polypeptides for use in a vaccine designed to induce virus-neutralizing antibodies.
Similar articles
-
Antigenic differences between the membrane antigen polypeptides determined by different EB virus isolates.J Gen Virol. 1981 Apr;53(Pt 2):371-6. doi: 10.1099/0022-1317-53-2-371. J Gen Virol. 1981. PMID: 6167667
-
Polypeptides of the Epstein-Barr virus membrane antigen complex.J Virol. 1979 Nov;32(2):458-67. doi: 10.1128/JVI.32.2.458-467.1979. J Virol. 1979. PMID: 228070 Free PMC article.
-
Quantification of an Epstein-Barr virus-associated membrane antigen component.J Virol Methods. 1982 Sep;5(1):55-65. doi: 10.1016/0166-0934(82)90097-0. J Virol Methods. 1982. PMID: 6292251
-
The Leeuwenhoek lecture, 1983. A prototype vaccine to prevent Epstein-Barr virus-associated tumours.Proc R Soc Lond B Biol Sci. 1984 Mar 22;221(1222):1-20. doi: 10.1098/rspb.1984.0019. Proc R Soc Lond B Biol Sci. 1984. PMID: 6144103 Review.
-
Transformation-associated tumor antigens.Adv Cancer Res. 1982;37:75-109. doi: 10.1016/s0065-230x(08)60882-9. Adv Cancer Res. 1982. PMID: 6190362 Review. No abstract available.
Cited by
-
Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins.J Virol. 1989 May;63(5):1967-74. doi: 10.1128/JVI.63.5.1967-1974.1989. J Virol. 1989. PMID: 2539497 Free PMC article.
-
Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo.J Virol. 1982 Aug;43(2):730-6. doi: 10.1128/JVI.43.2.730-736.1982. J Virol. 1982. PMID: 6287039 Free PMC article.
-
Identification of an Epstein-Barr virus nuclear antigen by fluoroimmunoelectrophoresis and radioimmunoelectrophoresis.J Virol. 1981 Jun;38(3):996-1004. doi: 10.1128/JVI.38.3.996-1004.1981. J Virol. 1981. PMID: 7017165 Free PMC article.
-
Neutralization of lymphocyte immortalization by different strains of Epstein-Barr virus with a murine monoclonal antibody.Infect Immun. 1982 Sep;37(3):1028-31. doi: 10.1128/iai.37.3.1028-1031.1982. Infect Immun. 1982. PMID: 6182100 Free PMC article.
-
Synthesis and processing of the three major envelope glycoproteins of Epstein-Barr virus.J Virol. 1983 May;46(2):547-56. doi: 10.1128/JVI.46.2.547-556.1983. J Virol. 1983. PMID: 6302318 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources